Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Avantor, Inc. (NYSE:AVTR - Get Rating) has been given an average recommendation of "Moderate Buy" by the sixteen analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $37.62.
AVTR has been the topic of a number of research analyst reports. Evercore ISI reduced their target price on Avantor to $35.00 in a research report on Tuesday, August 9th. Raymond James reduced their target price on Avantor from $40.00 to $36.00 and set an "outperform" rating on the stock in a research report on Monday, August 1st. Morgan Stanley reduced their target price on Avantor from $40.00 to $37.00 and set an "overweight" rating on the stock in a research report on Monday, August 1st. Barclays reduced their target price on Avantor to $33.00 in a research report on Tuesday, August 9th. Finally, TheStreet raised Avantor from a "c" rating to a "b-" rating in a research note on Thursday, May 19th.Avantor Stock Performance
Shares of Avantor stock opened at $25.55 on Monday. Avantor has a one year low of $25.53 and a one year high of $44.37. The company has a market cap of $17.22 billion, a price-to-earnings ratio of 27.47, a PEG ratio of 2.27 and a beta of 1.30. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64. The business's 50 day moving average price is $29.46 and its 200 day moving average price is $31.40.
Avantor (NYSE:AVTR - Get Rating) last posted its earnings results on Thursday, July 28th. The company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.01). Avantor had a net margin of 8.27% and a return on equity of 27.14%. The business had revenue of $1.91 billion during the quarter, compared to analysts' expectations of $1.98 billion. During the same quarter in the prior year, the firm earned $0.35 EPS. Avantor's revenue for the quarter was up 2.7% compared to the same quarter last year. On average, research analysts predict that Avantor will post 1.46 EPS for the current year. Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of AVTR. Norges Bank acquired a new position in Avantor during the 4th quarter worth $248,301,000. Steadfast Capital Management LP acquired a new position in Avantor during the 1st quarter worth $151,845,000. Allianz Asset Management GmbH grew its stake in Avantor by 43.5% during the 2nd quarter. Allianz Asset Management GmbH now owns 12,708,479 shares of the company's stock worth $395,233,000 after purchasing an additional 3,854,096 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Avantor by 3.8% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 86,156,553 shares of the company's stock worth $2,679,469,000 after purchasing an additional 3,164,276 shares in the last quarter. Finally, Point72 Asset Management L.P. grew its stake in Avantor by 184.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 4,315,143 shares of the company's stock worth $134,201,000 after purchasing an additional 2,797,974 shares in the last quarter. 93.24% of the stock is owned by institutional investors and hedge funds. About Avantor (Get Rating)
Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.Read MoreGet a free copy of the StockNews.com research report on Avantor (AVTR)Can NetApp Resume Its Rally After Strong Earnings Guidance? Three Reasons Why Medtronic Stock can be a Recession Winner Rivian Rising to the Challenge3 Deflation Enablers Stocks that Can Thrive in a RecessionWhy This Dip in Advanced Auto Parts May be an Opportunity
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.